200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 196597-26-9
CAS No: 196597-26-9 Catalog No: AG0038WF MDL No:MFCD08067736
Title | Journal |
---|---|
Cardiovascular effects of melatonin receptor agonists. | Expert opinion on investigational drugs 20121101 |
Ramelteon dose escalation in a patient with substance misuse. | Journal of clinical psychopharmacology 20121001 |
Ramelteon ingestions reported to Texas poison centers, 2005-2009. | The Journal of emergency medicine 20120901 |
Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system. | Central nervous system agents in medicinal chemistry 20120901 |
Emerging treatment for chronic migraine and refractory chronic migraine. | Expert opinion on emerging drugs 20120901 |
Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. | International journal of clinical practice 20120901 |
Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer. | Molecular carcinogenesis 20120801 |
Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon. | Chronobiology international 20120801 |
Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. | Clinical pharmacology and therapeutics 20120601 |
Pharmacotherapy of insomnia. | Expert opinion on pharmacotherapy 20120601 |
[New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance]. | Nihon rinsho. Japanese journal of clinical medicine 20120601 |
Melatonin and its analogs in insomnia and depression. | Journal of pineal research 20120501 |
[Delirium, insomnia in hospitalization and ramelteon]. | Nihon rinsho. Japanese journal of clinical medicine 20120501 |
[Report of the 5th meeting of Japanese Child Sleep Association]. | No to hattatsu = Brain and development 20120501 |
Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders. | CNS & neurological disorders drug targets 20120301 |
Chronic ramelteon treatment in a mouse model of Alzheimer's disease. | Archives italiennes de biologie 20120301 |
Augmentation with ramelteon to achieve remission in geriatric major depression. | Psychiatry and clinical neurosciences 20120201 |
The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease. | Parkinson's disease 20120101 |
Health care costs in US patients with and without a diagnosis of osteoarthritis. | Journal of pain research 20120101 |
Emerging targets for the pharmacological treatment of depression: focus on melatonergic system. | Current medicinal chemistry 20120101 |
The relationship of primary health care use with persistence of insomnia: a prospective cohort study. | BMC family practice 20120101 |
Hypnotics' association with mortality or cancer: a matched cohort study. | BMJ open 20120101 |
Circadian and wakefulness-sleep modulation of cognition in humans. | Frontiers in molecular neuroscience 20120101 |
cGMP-phosphodiesterase inhibition enhances photic responses and synchronization of the biological circadian clock in rodents. | PloS one 20120101 |
Gender differences in highway driving performance after administration of sleep medication: a review of the literature. | Traffic injury prevention 20120101 |
Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. | TheScientificWorldJournal 20120101 |
Recent progress in the development of agonists and antagonists for melatonin receptors. | Current medicinal chemistry 20120101 |
Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives. | Journal of medicinal chemistry 20111222 |
Melatonin receptor agonists: new options for insomnia and depression treatment. | CNS neuroscience & therapeutics 20111201 |
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. | Journal of clinical psychopharmacology 20111001 |
Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia. | Sleep medicine 20111001 |
Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia. | Expert review of neurotherapeutics 20111001 |
The challenges of interpreting residual effects of hypnotics. | Sleep 20111001 |
Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. | Sleep 20111001 |
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection. | Therapeutic advances in neurological disorders 20110901 |
An historical view of the pineal gland and mental disorders. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20110801 |
Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands. | Journal of medicinal chemistry 20110623 |
Ramelteon and improved insomnia in alcohol-dependent patients: a case series. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20110615 |
Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? | Progress in neuro-psychopharmacology & biological psychiatry 20110601 |
Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration. | Sleep medicine 20110601 |
Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization. | Current neuropharmacology 20110601 |
1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists. | Journal of medicinal chemistry 20110512 |
Insomnia: a therapeutic review for pharmacists. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110501 |
Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands. | Bioorganic & medicinal chemistry letters 20110215 |
Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder. | Journal of affective disorders 20110201 |
Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice. | Chronobiology international 20110201 |
Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. | Sleep medicine 20110201 |
Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia. | Sleep medicine 20110201 |
Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study. | Expert review of neurotherapeutics 20110201 |
A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance. | International clinical psychopharmacology 20110101 |
Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value. | International journal of Alzheimer's disease 20110101 |
Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. | Research in developmental disabilities 20110101 |
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications. | Neuroendocrinology 20110101 |
Pharmacological advances in the treatment of insomnia. | Current pharmaceutical design 20110101 |
Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm? | Journal of the American Society of Hypertension : JASH 20110101 |
Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). | International journal of general medicine 20110101 |
Melatonin in mitochondrial dysfunction and related disorders. | International journal of Alzheimer's disease 20110101 |
Clinical uses of melatonin in pediatrics. | International journal of pediatrics 20110101 |
Treatment of delirium with ramelteon: initial experience in three patients. | General hospital psychiatry 20110101 |
Efficient synthesis of [¹¹C]ramelteon as a positron emission tomography probe for imaging melatonin receptors involved in circadian rhythms. | Chemical & pharmaceutical bulletin 20110101 |
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia. | Drug, healthcare and patient safety 20110101 |
Melatonin in Chagas' disease. Possible therapeutic value. | Medicina 20110101 |
Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin. | Neuro endocrinology letters 20110101 |
Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215 |
Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20101215 |
Melatonin alters age-related changes in transcription factors and kinase activation. | Neurochemical research 20101201 |
Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. | Advances in therapy 20101101 |
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view. | Current drug metabolism 20101101 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. | Neurocase 20101001 |
Melatonin: pharmacological aspects and clinical trends. | The International journal of neuroscience 20100901 |
[The newer sedative-hypnotics]. | Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901 |
Neurotoxins: free radical mechanisms and melatonin protection. | Current neuropharmacology 20100901 |
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. | Current neuropharmacology 20100901 |
Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics. | Drug metabolism and disposition: the biological fate of chemicals 20100801 |
[Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701 |
Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. | Sleep medicine 20100601 |
Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep. | Sleep 20100601 |
Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats. | Annals of the New York Academy of Sciences 20100601 |
A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. | International clinical psychopharmacology 20100501 |
Potential use of melatonergic drugs in analgesia: mechanisms of action. | Brain research bulletin 20100316 |
MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus). | Endocrinology 20100201 |
Melatonin agonists and insomnia. | Expert review of neurotherapeutics 20100201 |
Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications. | The Journal of neuropsychiatry and clinical neurosciences 20100101 |
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. | BMC medicine 20100101 |
Diagnosis and treatment of chronic insomnia. | Annals of Indian Academy of Neurology 20100101 |
Insomnia medication use and the probability of an accidental event in an older adult population. | Drug, healthcare and patient safety 20100101 |
Indian research on sleep disorders. | Indian journal of psychiatry 20100101 |
Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings. | Brain research 20091103 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20091101 |
Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon. | The Journal of pharmacology and experimental therapeutics 20090901 |
Anticonvulsant effects of the selective melatonin receptor agonist ramelteon. | Epilepsy & behavior : E&B 20090901 |
Treatment of sleep dysfunction and psychiatric disorders. | Current treatment options in neurology 20090901 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090901 |
Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem). | P & T : a peer-reviewed journal for formulary management 20090901 |
Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090815 |
[A novel therapeutic drug: ramelteon]. | Nihon rinsho. Japanese journal of clinical medicine 20090801 |
Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture. | Psychopharmacology 20090701 |
Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat. | Neuroscience letters 20090626 |
Emerging therapies for sleep disorders. | British journal of hospital medicine (London, England : 2005) 20090601 |
Ramelteon: a review of its therapeutic potential in sleep disorders. | Advances in therapy 20090601 |
Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests. | Prescrire international 20090601 |
Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis. | Current medical research and opinion 20090501 |
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study. | The Journal of clinical psychiatry 20090401 |
[Objection to a conclusion in Medicinske Nyheder]. | Ugeskrift for laeger 20090330 |
The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease. | Sleep & breathing = Schlaf & Atmung 20090301 |
Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. | Human psychopharmacology 20090301 |
Ramelteon for the treatment of insomnia in menopausal women. | Menopause international 20090301 |
Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. | Sleep 20090301 |
Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215 |
Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090215 |
Let there be sleep--on time. | Lancet (London, England) 20090207 |
The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
The effects of ramelteon in a first-night model of transient insomnia. | Sleep medicine 20090101 |
Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. | CNS neuroscience & therapeutics 20090101 |
Melatonin and melatonergic drugs on sleep: possible mechanisms of action. | The International journal of neuroscience 20090101 |
New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. | Neuropsychiatric disease and treatment 20090101 |
Comparative tolerability of newer agents for insomnia. | Drug safety 20090101 |
Drugs associated with more suicidal ideations are also associated with more suicide attempts. | PloS one 20090101 |
Algorithms for the assessment and management of insomnia in primary care. | Patient preference and adherence 20090101 |
Can improving sleep influence sleep-disordered breathing? | Drugs 20090101 |
Neurophysiology of sleep and wakefulness: basic science and clinical implications. | Current neuropharmacology 20081201 |
Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20081015 |
Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat. | Critical care medicine 20081001 |
Melatonin and its agonists: an update. | The British journal of psychiatry : the journal of mental science 20081001 |
The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity. | Sleep 20081001 |
Ramelteon: new drug. Insomnia: no role for risky placebos. | Prescrire international 20081001 |
Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells. | Neuroscience 20080909 |
Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat. | Journal of pineal research 20080901 |
Ramelteon: a novel approach in the treatment of insomnia. | The Annals of pharmacotherapy 20080901 |
Sleep dysfunction in heart failure. | Current treatment options in neurology 20080901 |
Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep? | Journal of sleep research 20080901 |
Possibility that certain hypnotics might cause cancer in skin. | Journal of sleep research 20080901 |
Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD. | Sleep & breathing = Schlaf & Atmung 20080801 |
Efficacy and clinical safety of ramelteon: an evidence-based review. | Sleep medicine reviews 20080801 |
Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells. | Neuroscience letters 20080704 |
Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. | Clinical therapeutics 20080701 |
Pharmacotherapy for insomnia. | Clinics in geriatric medicine 20080201 |
A review of ramelteon in the treatment of sleep disorders. | Neuropsychiatric disease and treatment 20080201 |
[Drugs for insomnia and improving quality of life (QOL): research and development of ramelteon, an MT1/MT2-receptor agonist]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080101 |
Ramelteon: a melatonin receptor agonist for the treatment of insomnia. | Journal of postgraduate medicine 20080101 |
Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. | Travel medicine and infectious disease 20080101 |
Melatonergic drugs in clinical practice. | Arzneimittel-Forschung 20080101 |
Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial. | Critical care (London, England) 20080101 |
Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders. | Current topics in medicinal chemistry 20080101 |
Ramelteon: a review of its use in insomnia. | Drugs 20080101 |
Indiplon in the treatment of sleep disorders. | Neuropsychiatric disease and treatment 20071201 |
In search of novel and therapeutically significant melatoninergic ligands. | Recent patents on CNS drug discovery 20071101 |
Design and synthesis of new N1 and C3-substituted 4-fluoroindolic melatoninergics. | Current drug discovery technologies 20071001 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20071001 |
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. | Sleep & breathing = Schlaf & Atmung 20070901 |
Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. | The American journal of geriatric pharmacotherapy 20070901 |
Eszopiclone for late-life insomnia. | Clinical interventions in aging 20070901 |
Ramelteon: a novel hypnotic indicated for the treatment of insomnia. | Psychiatry (Edgmont (Pa. : Township)) 20070901 |
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815 |
Treatment options for insomnia. | American family physician 20070815 |
Putting 'sleepdriving' and new safety warning in perspective. | The Johns Hopkins medical letter health after 50 20070801 |
Eszopiclone: its use in the treatment of insomnia. | Neuropsychiatric disease and treatment 20070801 |
New perspectives for the treatment of disorders of sleep and arousal. | Annales pharmaceutiques francaises 20070701 |
Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. | Current medical research and opinion 20070601 |
The management of insomnia in the older adult. | Medicine and health, Rhode Island 20070601 |
Hypnotic sedative drugs. | Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20070601 |
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia. | Current medical research and opinion 20070501 |
Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2. | Journal of clinical pharmacology 20070401 |
Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon. | Nature clinical practice. Neurology 20070401 |
Putting insomnia to rest. | The Nurse practitioner 20070401 |
Therapeutic options for sleep-maintenance and sleep-onset insomnia. | Pharmacotherapy 20070101 |
[Recent and potential drugs for treatment of insomnia]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070101 |
Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? | CNS drugs 20070101 |
[Melatonin, melatonin receptor agonists and tryptophan as sleep aids]. | Pharmazie in unserer Zeit 20070101 |
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care. | Primary care companion to the Journal of clinical psychiatry 20070101 |
Greater incidence of depression with hypnotic use than with placebo. | BMC psychiatry 20070101 |
Role of the melatonin system in the control of sleep: therapeutic implications. | CNS drugs 20070101 |
[New hypnotics: perspectives from sleep physiology]. | Vertex (Buenos Aires, Argentina) 20070101 |
Treating insomnia: Current and investigational pharmacological approaches. | Pharmacology & therapeutics 20061201 |
Pharmacologic management of insomnia: past, present, and future. | The Psychiatric clinics of North America 20061201 |
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. | Archives of general psychiatry 20061001 |
Ramelteon for insomnia in two youths with autistic disorder. | Journal of child and adolescent psychopharmacology 20061001 |
Ramelteon for the treatment of insomnia. | Clinical therapeutics 20061001 |
A new sleeping pill. | The Harvard mental health letter 20061001 |
Treatment of sleep dysfunction and psychiatric disorders. | Current treatment options in neurology 20060901 |
Associated Professional Sleep Societies--SLEEP 2006 20th Anniversary Meeting. 17-22 June 2006, Salt Lake City, UT, USA. | IDrugs : the investigational drugs journal 20060901 |
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II. | Journal of psychiatric practice 20060901 |
New drugs 06, part II. | Nursing 20060801 |
Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice. | Neuroscience letters 20060724 |
Ramelteon: a novel treatment for the treatment of insomnia. | Expert review of neurotherapeutics 20060701 |
Searching for new options for treating insomnia: are melatonin and ramelteon beneficial? | Journal of psychiatric practice 20060701 |
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. | Sleep medicine 20060601 |
Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies. | Behavioral neuroscience 20060601 |
Management of chronic insomnia in elderly persons. | The American journal of geriatric pharmacotherapy 20060601 |
Depression and sleep: pathophysiology and treatment. | Dialogues in clinical neuroscience 20060601 |
Consultation corner. Are the new sleep aids right for you? | The Johns Hopkins medical letter health after 50 20060401 |
Potential therapeutic use of melatonin in migraine and other headache disorders. | Expert opinion on investigational drugs 20060401 |
Ramelteon (rozerem) a novel approach for insomnia treatment. | The Nurse practitioner 20060401 |
Practical considerations of new drugs: new choices for old problems. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401 |
Ramelteon: profile of a new sleep-promoting medication. | Drugs of today (Barcelona, Spain : 1998) 20060401 |
Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. | Journal of clinical pharmacology 20060201 |
A look back at the most influential drug approvals of 2005. | The Nurse practitioner 20060201 |
Recommendations for assessing insomnia. | The Nurse practitioner 20060201 |
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. | Sleep medicine 20060101 |
New drugs: ramelteon, tipranavir, nepafenac, and deferasirox. | Journal of the American Pharmacists Association : JAPhA 20060101 |
Use of sleep-promoting medications in nursing home residents : risks versus benefits. | Drugs & aging 20060101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20060101 |
Melatonin and sleep in aging population. | Experimental gerontology 20051201 |
Ramelteon (Rozerem) for insomnia. | The Medical letter on drugs and therapeutics 20051107 |
Fresh from the pipeline: Ramelteon. | Nature reviews. Drug discovery 20051101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20051001 |
New drugs and dosage forms. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050915 |
Recent advances in melatonin receptor ligands. | Archiv der Pharmazie 20050601 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20050401 |
Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. | Sleep 20050301 |
Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. | Journal of biological rhythms 20050201 |
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. | Neuropharmacology 20050201 |
TAK-375 Takeda. | Current opinion in investigational drugs (London, England : 2000) 20050101 |
Ramelteon: TAK 375. | Drugs in R&D 20050101 |
Ramelteon. | CNS drugs 20050101 |
Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. | The Journal of clinical psychiatry 20050101 |
Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. | The Journal of clinical psychiatry 20050101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041201 |
Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys. | Brain research 20041119 |
Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. | Sleep medicine 20041101 |
The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. | Sleep 20041101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20031101 |
Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. | Journal of medicinal chemistry 20020912 |
© 2019 Angene International Limited. All rights Reserved.